Citigroup’s Astria Therapeutics ATXS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $164K | Sell |
30,540
-4,633
| -13% | -$24.8K | ﹤0.01% | 3435 |
|
|
2025
Q1 | $188K | Sell |
35,173
-18,824
| -35% | -$101K | ﹤0.01% | 3478 |
|
|
2024
Q4 | $483K | Buy |
53,997
+19,951
| +59% | +$178K | ﹤0.01% | 3051 |
|
|
2024
Q3 | $375K | Buy |
34,046
+14,010
| +70% | +$154K | ﹤0.01% | 3169 |
|
|
2024
Q2 | $182K | Sell |
20,036
-138,539
| -87% | -$1.26M | ﹤0.01% | 3215 |
|
|
2024
Q1 | $2.23M | Buy |
158,575
+153,835
| +3,245% | +$2.17M | ﹤0.01% | 1767 |
|
|
2023
Q4 | $36.4K | Buy |
4,740
+4,727
| +36,362% | +$36.3K | ﹤0.01% | 3936 |
|
|
2023
Q3 | $97 | Sell |
13
-13,477
| -100% | -$101K | ﹤0.01% | 4647 |
|
|
2023
Q2 | $112K | Buy |
13,490
+4,717
| +54% | +$39.3K | ﹤0.01% | 3521 |
|
|
2023
Q1 | $117K | Buy |
+8,773
| New | +$117K | ﹤0.01% | 3338 |
|
|
2021
Q3 | – | Sell |
-453
| Closed | -$6K | – | 4984 |
|
|
2021
Q2 | $6K | Buy |
453
+213
| +89% | +$2.82K | ﹤0.01% | 5109 |
|
|
2021
Q1 | $4K | Sell |
240
-382
| -61% | -$6.37K | ﹤0.01% | 5260 |
|
|
2020
Q4 | $8K | Buy |
622
+468
| +304% | +$6.02K | ﹤0.01% | 4918 |
|
|
2020
Q3 | $6K | Sell |
154
-249
| -62% | -$9.7K | ﹤0.01% | 4535 |
|
|
2020
Q2 | $16K | Buy |
+403
| New | +$16K | ﹤0.01% | 4381 |
|
|
2017
Q1 | – | Sell |
-44
| Closed | -$9K | – | 4796 |
|
|
2016
Q4 | $9K | Buy |
+44
| New | +$9K | ﹤0.01% | 4542 |
|
|
2016
Q2 | – | Sell |
-63
| Closed | -$19K | – | 4946 |
|
|
2016
Q1 | $19K | Buy |
+63
| New | +$19K | ﹤0.01% | 4604 |
|
|
2015
Q4 | – | Sell |
-26
| Closed | -$13K | – | 5386 |
|
|
2015
Q3 | $13K | Buy |
+26
| New | +$13K | ﹤0.01% | 4268 |
|